These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6299185)

  • 1. Comparison study of the kinetics of ceftizoxime penetration into extravascular spaces with known surface area/volume ratio in vitro and in vivo in rabbits.
    Van Etta LL; Fasching CE; Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1983 Jan; 23(1):49-53. PubMed ID: 6299185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serum protein binding and multiple antibiotic doses in the extravascular distribution of ceftizoxime and cefotaxime.
    Gerding DN; Van Etta LL; Peterson LR
    Antimicrob Agents Chemother; 1982 Nov; 22(5):844-7. PubMed ID: 6295269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin penetration into extravascular spaces in a rabbit model.
    Nichol KL; Peterson LR; Fasching CE; Gerding DN
    Antimicrob Agents Chemother; 1984 Dec; 26(6):935-6. PubMed ID: 6524907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of protein binding on simulated intravascular and extravascular kinetics of cefotaxime in an in vitro model.
    Peterson LR; Van Etta LL; Fasching CE; Gerding DN
    Antimicrob Agents Chemother; 1984 Jan; 25(1):58-61. PubMed ID: 6322682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the ratio of surface area to volume on the penetration of antibiotics in to extravascular spaces in an in vitro model.
    Van Etta LL; Peterson LR; Fasching CE; Gerding DN
    J Infect Dis; 1982 Sep; 146(3):423-8. PubMed ID: 7108283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of cefazolin penetration in high- and low-protein-containing extravascular fluid: new method for performing simultaneous studies.
    Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1978 Oct; 14(4):533-8. PubMed ID: 718152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjects.
    Peterson LR; Gerding DN; Van Etta LL; Eckfeldt JH; Larson TA
    Antimicrob Agents Chemother; 1982 Nov; 22(5):878-81. PubMed ID: 6295270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
    Peterson LR; Gerding DN; Moody JA; Fasching CE
    Antimicrob Agents Chemother; 1984 May; 25(5):545-52. PubMed ID: 6329087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative tissue and extravascular fluid concentrations of ceftizoxime.
    Gerding DN; Peterson LR
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():105-16. PubMed ID: 6295995
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of protein binding on drug penetration into blister fluid.
    Shyu WC; Quintiliani R; Nightingale CH; Dudley MN
    Antimicrob Agents Chemother; 1988 Jan; 32(1):128-30. PubMed ID: 3162360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of ceftizoxime, a new cephalosporin. Single-dose study.
    Nakashima N; Suzuki K; Hashimoto H; Nishijima K
    J Clin Pharmacol; 1981 Oct; 21(10):388-95. PubMed ID: 6273456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftizoxime kinetics and renal handling.
    Dubb J; Actor P; Pitkin D; Alexander F; Familiar R; Ehrlich S; Stote R
    Clin Pharmacol Ther; 1982 Apr; 31(4):516-21. PubMed ID: 6277546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extravascular penetration of tobramycin and netilmicin in a subcutaneous visking chamber model in rabbits.
    Larson TA; Gerding DN; Peterson LR
    Antimicrob Agents Chemother; 1983 Oct; 24(4):594-6. PubMed ID: 6651282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.
    Gerding DN; Peterson LR; Moody JA; Fasching CE
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():207-19. PubMed ID: 3856563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of ceftizoxime compared with that of cefamandole.
    Neu HC; Srinivasan S
    Antimicrob Agents Chemother; 1981 Sep; 20(3):366-9. PubMed ID: 6272631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of method of administration on extravascular penetration of four antibiotics.
    Van Etta LL; Kravitz GR; Russ TE; Fasching CE; Gerding DN; Peterson LR
    Antimicrob Agents Chemother; 1982 Jun; 21(6):873-80. PubMed ID: 7114835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of multiple doses of ceftizoxime and their influence on fecal flora.
    Lode H; Warns H; Kemmerich B; Knothe H; Koeppe P
    Eur J Clin Microbiol; 1983 Apr; 2(2):116-21. PubMed ID: 6305648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
    Burgess ED; Blair AD
    Antimicrob Agents Chemother; 1983 Aug; 24(2):237-9. PubMed ID: 6314887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ceftizoxime in subjects with various degrees of renal function.
    Kowalsky SF; Echols RM; Venezia AR; Andrews EA
    Antimicrob Agents Chemother; 1983 Aug; 24(2):151-5. PubMed ID: 6314884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of probenecid on the pharmacokinetics of ceftizoxime.
    LeBel M; Paone RP; Lewis GP
    J Antimicrob Chemother; 1983 Aug; 12(2):147-55. PubMed ID: 6311785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.